Technology Outlook
QQQ
Nasdaq
Semiconductors

Tech Daily: The Capex Paradox (AMZN Dumps, NVDA Pumps)

Tobin Kennedy
February 6, 2026, 10:30 AM EST
5 min read

PART 1: THE TECH DASHBOARD (10:30 AM ET)

Asset Value Session Context
QQQ (Nasdaq-100) $508.45 Lagging / Dragged by AMZN (-9%)
SOX (Semiconductors) $5,120.50 Relative Strength Leader (+1.8%)
US10Y Yield 4.19% Benign (-1bp) / Non-Factor Today
VXN (Nasdaq Vol) 18.45 Elevated (Contango Slope)
NVDA $142.20 Session Leader (+3.1%)

PART 2: THE TECH-GROWTH NARRATIVE

  • The Capex Transfer: The dominant theme today is a massive sector rotation triggered by Amazon. AMZN's 50% jump in capex (forecasting ~$200B) is crushing its own stock (-9%) and dragging down other hyperscalers (GOOGL, META) on margin fears. However, that spending is revenue for the Semiconductor complex. We are seeing a clean "Short the Spender, Long the Seller" dynamic.
  • Yields Are Not The Story: With the US10Y stable at 4.19%, the sell-off in software is idiosyncratic, not macro-driven. This confirms the market is punishing "AI cost" without immediate "AI return," while rewarding the infrastructure providers (NVDA, AVGO, TSM).
  • Mag 7 Fracture: "The Seven" are broken. NVDA and TSLA (via sentiment) are decoupling from the software giants. This is no longer a monolithic trade; it's a stock-picker's market within the Nasdaq.

PART 3: THE MID-SESSION TECH THESIS

  • Primary Scenario: The "Forked" Market. Expect QQQ to remain heavy and range-bound, capped by AMZN's massive weighting (and the psychological damage to MSFT/GOOGL holders). Conversely, look for the SOX (Semiconductors) to grind higher, potentially testing intraday highs as funds rotate exposure into "hard tech."
  • The Tech Pivot: QQQ $506.50. This is the morning support shelf. If QQQ loses $506.50, the "NVDA support" thesis fails, and we likely flush to fill the weekly gap lower. Holding above keeps the "Rotation" thesis alive.
  • Flow & Skew: Heavy Put buying in AMZN is distorting the QQQ skew. However, we are seeing aggressive Call buying in NVDA and AVGO weekly expiries, confirming the rotation narrative.

PART 4: ACTIONABLE TECH TRADE PLANS

  • [TRADE #1: QQQ 0-DTE / SHORT-DATED]

    • Strategy: Bear Call Spread (Credit Spread)
    • Strikes: Sell $512 Calls / Buy $514 Calls (Exp: Today/Monday)
    • Logic: Upside is capped by the sheer drag of AMZN and the "Show Me" attitude towards Hyperscaler capex. Even if Semis rally, they have to lift a very heavy anchor. We fade rallies into VWAP.
  • [TRADE #2: THE ALPHA FOCUS (NVDA)]

    • Strategy: Bull Call Vertical (Debit Spread)
    • Strikes: Buy $142 Call / Sell $146 Call (Exp: Feb 13 Weekly)
    • Risk/Reward: Risk ~35% of width to make ~65%.
    • Logic: Amazon's pain is Nvidia's direct gain. The $200B capex number is effectively a guaranteed backlog for Blackwell/Rubin chips. We play the momentum breakout as NVDA ignores the broader tech weakness.

PART 5: 1DTE SPX OPTION RECOMMENDATIONS

  • Trade Idea: Monday Expiry Iron Condor (Neutral/Wide)
    • Strikes: Short 5980 Put / Short 6050 Call (Unbalanced, leaning short delta).
    • Rationale: The S&P 500 is caught between defensive strength (Value/energy holding up) and Tech weakness. We expect a "Pin" effect into the weekend.
    • Risk Management: Stop loss on the Call side spread if SPX breaks 6035 with volume. The Put side is likely safer given the macro yield stability.

TradeScope Risk Disclosure: Trading derivatives involves high risk and is not suitable for all investors. Past performance is not indicative of future results. All content is for educational purposes only and does not constitute financial advice.

Important Risk Disclosure & AI Transparency

This content is AI-generated and experimental. The information provided in this analysis is for educational and informational purposes only and should not be construed as financial advice. Trading and investing in financial markets involves substantial risk of loss and is not suitable for every investor. Options trading can result in complete loss of capital.

TradeScopeDaily.com is not a registered investment advisor. Data may be inaccurate, delayed, or incomplete. Past performance is not indicative of future results. Always verify information through regulated sources and consult with qualified financial professionals before making any investment decisions.

Read Full Risk Disclosure & AI Transparency Notice →